Geron Corp (NASDAQ:GERN)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

Caps

How do you think GERN will perform against the market?

Add Stock to CAPS Watchlist

All Players

662 Outperform
64 Underperform
 

All-Star Players

83 Outperform
20 Underperform
 

Wall Street

8 Outperform
2 Underperform
 

Top GERN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jahnjf (33.02)
Submitted April 30, 2018

All clinical trials pointing to approval of game changer drug.

SwingCorey (< 20)
Submitted January 11, 2010

Embryonic stem cell research, regardless of the current presidential/congressional support, is in trouble. They have not figured out how to fix the problems (e.g. cancerous tumors), yet "adult" stem cells (e.g., from dental pulp, bone marrow, and… More

GERN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about GERN.

Recs

0
Member Avatar pchop12316 (92.68) Submitted: 11/7/2018 10:12:43 AM : Outperform Start Price: $1.67 GERN Score: -4.72

has new energy for a run up

Recs

0
Member Avatar TerryHogan (99.97) Submitted: 10/7/2018 3:16:01 AM : Underperform Start Price: $1.82 GERN Score: +9.21

Hate to red-thumb after such a huge drop, but there are no sales, no profits, and continued large share issuances. Red Thumb.

Recs

0
Member Avatar streetdan (< 20) Submitted: 9/9/2018 10:31:50 AM : Outperform Start Price: $6.15 GERN Score: -69.01

This company has found an effective cancer treatment that has only a relatively small, easily managed toxicity. It is on the frontier of not only being a potential stand alone agent, but also may improve other cancer agents when used in combination. They have therefore an agent that can disrupt cancers progression without significant harm to normal cells.

Leaderboard

Find the members with the highest scoring picks in GERN.

Score Leader

Ravelin

Ravelin (< 20) Score: +412.10

The Score Leader is the player with the highest score across all their picks in GERN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SheepInvstr213 < 20 3/9/2009 Underperform 5Y $4.59 -66.03% +305.52% +371.55 0 Comment
epc53 27.80 3/3/2009 Underperform NS $3.85 -59.48% +293.47% +352.95 0 Comment
Dudeone 85.24 3/12/2009 Underperform 5Y $4.32 -63.89% +272.62% +336.51 0 Comment
kevleeyang 70.37 1/23/2009 Underperform NS $7.23 -78.42% +234.53% +312.96 0 Comment
e2003 96.65 3/30/2009 Underperform 1Y $4.75 -67.16% +245.32% +312.47 0 Comment
js2776 < 20 1/26/2009 Underperform 3Y $8.15 -80.86% +231.38% +312.23 2 Comments
dcfoolz 70.39 1/26/2009 Underperform 5Y $7.47 -79.12% +231.73% +310.85 0 Comment
Lafleur526 31.00 1/26/2009 Underperform 3W $7.47 -79.12% +231.73% +310.85 0 Comment
yourfavoritepers 81.97 1/26/2009 Underperform 3W $7.47 -79.12% +231.73% +310.85 0 Comment
SheepInvstr321 91.84 1/23/2009 Underperform 5Y $7.36 -78.80% +231.18% +309.98 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 85.23 8/12/2013 Outperform NS $1.59 -1.89% +61.75% -63.64 0 Comment
TrackPiperJaff 85.23 1/18/2013 Outperform NS $1.78 -30.90% +5.76% -36.66 3/14/2013 @ $1.23 0 Comment
TrackPoisedTo < 20 8/31/2012 Underperform 5Y $2.64 -40.91% +92.86% +133.77 0 Comment
TrackStifel 91.86 8/30/2012 Outperform NS $2.57 -39.30% +93.39% -132.69 0 Comment
trackwbbsecuriti < 20 11/16/2011 Outperform NS $1.68 -7.14% +118.32% -125.47 0 Comment
TrackRodmanRen < 20 1/23/2009 Outperform NS $7.04 -77.84% +241.08% -318.92 0 Comment
trackmerriman 68.62 12/11/2008 Outperform NS $4.29 -63.64% +208.96% -272.60 0 Comment
TrackUBS 91.93 1/29/2008 Outperform NS $5.00 -68.80% +108.66% -177.46 0 Comment
TrackEveillard 95.82 9/30/2007 Outperform NS $7.32 -78.69% +87.11% -165.80 2 Comments
TrackTobinSmith < 20 11/11/2006 Outperform 1Y $8.59 -81.84% +109.22% -191.06 0 Comment
TrackJimCramer 85.26 3/24/2006 Underperform 3W $8.33 -81.21% +123.51% +204.72 0 Comment

Advertisement